Oramed Pharmaceuticals Inc.

Director's Dealing • May 2, 2023

Form 8-K - Director Appointment false

����� ����������� ����	2 380
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008	14166
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	01/05/2023
	www.isa.gov.il			www.tase.co.il				Reference:	2023-02-046776	Time of broadcast: 23:59 23:59

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onForm 8-K - Director Appointment

Form_8-K_Ben_Shapiro_Director_Appointment_May_1_2023_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 21/02/2023
Address: Avenue of the Americas 01185 , New York 10036   New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com   Company site: www.oramed.com
Previous names of reporting entity:
Name of the Signatory: DEROVAN NETANEL MOSHE Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Mamila 20 , Jerusalem 9414904 Telephone: 02-5660001 Facsimile: E-mail: netanel@oramed.com 1
USA